TB-Related Articles

Return to Main Menu

2023 DTBE Publications

Adams T, Miller K, Law M, Pitcher E, Chinpar B, White K, Deutsch-Feldman M, Li R, Filardo TD, Romieu-Hernandez AC, Schwartz NG, Haddad MB, Glowicz J. Systematic contact investigation: an essential infection prevention skill to prevent tuberculosis transmission in healthcare settings. Am J Infect Control. 2023 Jun 22:S0196-6553(23)00478-9. doi: 10.1016/j.ajic.2023.06.014. Epub ahead of print. PMID: 37355098.

Baker JJ, Nahar R, Petroelje BK, Goswami ND, Lardizabal AA. Fluoroquinolone-resistant latent tuberculosis infection: A literature review and case series of 5 patients treated with linezolid monotherapy. J Clin Tuberc Other Mycobact Dis. 2023 May 18;32:100376. doi: 10.1016/j.jctube.2023.100376. PMID: 37252368; PMCID: PMC10209533.

Feng PI, Horne DJ, Wortham JM, Katz DJ; CDC Tuberculosis Epidemiologic Studies Consortium. Trends in tuberculosis clinicians’ adoption of short-course regimens for latent tuberculosis infection. J Clin Tuberc Other Mycobact Dis. 2023 Jun 13;33:100382. doi: 10.1016/j.jctube.2023.100382. PMID: 37416302; PMCID: PMC10320582.

Haley CA, Schechter MC, Ashkin D, Peloquin CA, Cegielski JP, Andrino BB, Burgos M, Caloia LA, Chen L, Colon-Semidey A, DeSilva MB, Dhanireddy S, Dorman SE, Dworkin FF, Hammond-Epstein H, Easton AV, Gaensbauer JT, Ghassemieh B, Gomez ME, Horne D, Jasuja S, Jones BA, Kaplan LJ, Khan AE, Kracen E, Labuda S, Landers KM, Lardizabal AA, Lasley MT, Letzer DM, Lopes VK, Lubelchek RJ, Macias CP, Mihalyov A, Misch EA, Murray JA, Narita M, Nilsen DM, Ninneman MJ, Ogawa L, Oladele A, Overman M, Ray SM, Ritger KA, Rowlinson MC, Sabuwala N, Schiller TM, Schwartz LE, Spitters C, Thomson DB, Tresgallo RR, Valois P, Goswami ND; BPaL Implementation Group. Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-resistant or rifampin-intolerant TB disease. Clin Infect Dis. 2023 May 30:ciad312. doi: 10.1093/cid/ciad312. Epub ahead of print. PMID: 37249079.

Kurbatova EV, Phillips PP, Dorman SE, Sizemore EE, Bryant KE, Purfield AE, Ricaldi J, Brown NE, Johnson JL, Wallis CL, Akol JP, Ocheretina O, Van Hung N, Mayanja-Kizza H, Lourens M, Dawson R, Nhung NV, Pierre S, Musodza Y, Shenje J, Badal-Faesen S, Vilbrun SC, Waja Z, Peddareddy L, Scott NA, Yuan Y, Vernon A, Goldberg SV, Swindells S, Chaisson RE, Nahid P; AIDS Clinical Trials Group and the Tuberculosis Trials Consortium. A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase TB Trials. Am J Respir Crit Care Med. 2023 Feb 15. doi: 10.1164/rccm.202206-1118OC. Epub ahead of print. PMID: 36790881.

Li R, Deutsch-Feldman M, Adams T, Law M, Biak C, Pitcher E, Drees M, Hernandez-Romieu AC, Filardo TD, Cropper T, Martinez A, Wilson WW, Althomsons SP, Morris SB, Wortham JM, Benowitz I, Schwartz NG, White K, Haddad MB, Glowicz JB; Bone Allograft Tuberculosis Investigators. Transmission of Mycobacterium tuberculosis to healthcare personnel resulting from contaminated bone graft material, United States, June 2021- August 2022. Clin Infect Dis. 2023 Jan 20:ciad029. doi: 10.1093/cid/ciad029. Epub ahead of print. PMID: 36660866.

Mangan JM, Woodruff RS, Winston CA, Nabity SA, Haddad MB, Dixon MG, Parvez FM, Sera-Josef C, Salmon-Trejo LAT, Lam CK. Recommendations for Use of Video Directly Observed Therapy During Tuberculosis Treatment – United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Mar 24;72(12):313-316. doi: 10.15585/mmwr.mm7212a4. PMID: 36952279; PMCID: PMC10042619.

Marks SM, Self JL, Venkatappa T, Wolff MB, Hopkins PB, Augustine RJ, Khan A, Schwartz NG, Schmit KM, Morris SB. Diagnosis, Treatment, and Prevention of Tuberculosis Among People Experiencing Homelessness in the United States: Current Recommendations. Public Health Rep. 2023 Jan 26:333549221148173. doi: 10.1177/00333549221148173. Epub ahead of print. PMID: 36703605.

Sadowski C, Belknap R, Holland DP, Moro RN, Chen MP, Wright A, Millet JP, Caylà JA, Scott NA, Borisov A, Gandhi NR. Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection. Clin Infect Dis. 2023 Jun 16;76(12):2090-2097. doi: 10.1093/cid/ciad083. PMID: 36815322; PMCID: PMC10273365.

Schildknecht KR, Pratt RH, Feng PI, Price SF, Self JL. Tuberculosis – United States, 2022. MMWR Morb Mortal Wkly Rep. 2023 Mar 24;72(12):297-303. doi: 10.15585/mmwr.mm7212a1. PMID: 36952282; PMCID: PMC10042618.

Scott NA, Sadowski C, Vernon A, Arevalo B, Beer K, Borisov A, Cayla JA, Chen M, Feng PJ, Moro RN, Holland DP, Martinson N, Millet JP, Miro JM, Belknap R. Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine. Contemp Clin Trials. 2023 Jun;129:107173. doi: 10.1016/j.cct.2023.107173. Epub 2023 Mar 31. PMID: 37004811.

Stalter RM, Pecha M, Dov L, Miller D, Ghazal Z, Wortham J, Althomsons S, Deutsch-Feldman M, Stewart R, Felix D, Hsu S, Strick LB. Tuberculosis Outbreak in a State Prison System – Washington, 2021-2022. MMWR Morb Mortal Wkly Rep. 2023 Mar 24;72(12):309-312. doi: 10.15585/mmwr.mm7212a3. PMID: 36952619; PMCID: PMC10042616.

Venkatappa T, Shen D, Ayala A, Li R, Sorri Y, Punnoose R, Katz D; Tuberculosis Epidemiologic Studies Consortium. Association of Mycobacterium tuberculosis infection test results with risk factors for tuberculosis transmission. J Clin Tuberc Other Mycobact Dis. 2023 Jun 29;33:100386. doi: 10.1016/j.jctube.2023.100386. PMID: 37426113; PMCID: PMC10328964.

Winters N, Belknap R, Benedetti A, Borisov A, Campbell JR, Chaisson RE, Chan PC, Martinson N, Nahid P, Scott NA, Sizemore E, Sterling TR, Villarino ME, Wang JY, Menzies D. Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis. Lancet Respir Med. 2023 Mar 23:S2213-2600(23)00096-6. doi: 10.1016/S2213-2600(23)00096-6. Epub ahead of print. PMID: 36966788.

Zavala S, Winglee K, Ho CS, Pettit AC, Ahmed A, Katz DJ, Belknap RW, Stout JE; Tuberculosis Epidemiologic Studies Consortium. Examining Test Cutoffs to Optimize Diagnosis of Latent Tuberculosis Infection in Non-US-born People. Ann Am Thorac Soc. 2023 May 9. doi: 10.1513/AnnalsATS.202212-1005OC. Epub ahead of print. PMID: 37159954.